0000000000190052

AUTHOR

Antonia Pignolo

0000-0002-8883-5701

showing 11 related works from this author

Assessment of the Kinematic Adaptations in Parkinson’s Disease Using the Gait Profile Score: Influences of Trunk Posture, a Pilot Study

2021

Introduction: Postural abnormalities are common in patients with Parkinson’s disease (PD) and lead to gait abnormalities. Relationships between changes in the trunk posture of PD patients and gait profile score (GPS) and gait spatiotemporal parameters are poorly investigated. The aim of the current study was to investigate the relationships between trunk posture, GPS, and gait spatiotemporal parameters, in patients with PD. Materials and Methods: Twenty-three people with PD and nineteen age-matched healthy people participated in this study. A 3D gait kinematical analysis was applied to all participants using the Plug-In Gait Full BodyTM tool. Trunk and limb kinematics patterns and gait spat…

trunk flexionkinematicsGeneral Neuroscienceposture; gait; Parkinson’s disease; trunk flexion; kinematicsParkinson’s diseaseNeurosciences. Biological psychiatry. Neuropsychiatrygaithuman activitiesArticlepostureRC321-571Brain Sciences; Volume 11; Issue 12; Pages: 1605
researchProduct

Inherited Neuromuscular Disorders: Which Role for Serum Biomarkers?

2021

Inherited neuromuscular disorders (INMD) are a heterogeneous group of rare diseases that involve muscles, motor neurons, peripheral nerves or the neuromuscular junction. Several different lab abnormalities have been linked to INMD: sometimes they are typical of the disorder, but they usually appear to be less specific. Sometimes serum biomarkers can point out abnormalities in presymtomatic or otherwise asymptomatic patients (e.g., carriers). More often a biomarker of INMD is evaluated by multiple clinicians other than expert in NMD before the diagnosis, because of the multisystemic involvement in INMD. The authors performed a literature search on biomarkers in inherited neuromuscular disord…

0303 health sciencesHeterogeneous groupbusiness.industryGeneral Neurosciencebiomarkersrare diseasesinherited neuromuscular disordersReviewBioinformaticsAsymptomaticlcsh:RC321-57103 medical and health sciences0302 clinical medicineSerum biomarkersmedicineBiomarker (medicine)Settore MED/26 - Neurologiamedicine.symptombusinesslcsh:Neurosciences. Biological psychiatry. Neuropsychiatry030217 neurology & neurosurgery030304 developmental biologyBrain Sciences
researchProduct

Patisiran Enhances Muscle Mass after Nine Months of Treatment in ATTRv Amyloidosis: A Study with Bioelectrical Impedance Analysis and Handgrip Streng…

2022

Background and aims. Hereditary transthyretin amyloidosis with polyneuropathy (ATTRv) is caused by mutations in the TTR gene, leading to misfolded monomers that aggregate generating amyloid fibrils. The clinical phenotype is heterogeneous, characterized by a multisystemic disease affecting the sensorimotor, autonomic functions along with other organs. Patisiran is a small interfering RNA acting as a TTR silencer approved for the treatment of ATTRv. Punctual and detailed instrumental biomarkers are on demand for ATTRv to measure the severity of the disease and monitor progression and response to treatment. Methods. Fifteen patients affected by ATTRv amyloidosis (66.4 ± 7.8 years, six males) …

handgrip strengthpatisiranhereditary amyloid neuropathy; ATTRv; TTR; handgrip strength; bioelectrical impedance analysis; patisiranATTRvMedicine (miscellaneous)bioelectrical impedance analysishereditary amyloid neuropathyTTRGeneral Biochemistry Genetics and Molecular BiologyBiomedicines; Volume 11; Issue 1; Pages: 62
researchProduct

Clinical and Neurophysiological Follow-Up of Chronic Inflammatory Demyelinating Polyneuropathy Patients Treated with Subcutaneous Immunoglobulins: A …

2022

Background: chronic idiopathic demyelinating polyneuropathy (CIDP) is an acquired, immune-mediated neuropathy characterized by weakness, sensory symptoms and significant reduction or loss of deep tendon reflexes evolving over 2 months at least, associated with electrophysiological evidence of peripheral nerve demyelination. Recently, subcutaneous immunoglobulins (SCIg) have been introduced in clinical practice as a maintenance therapy for CIDP; nevertheless, electrophysiological and efficacy data are limited. Methods: to evaluate SCIg treatment efficacy, we retrospectively reviewed data from 15 CIDP patients referring to our clinic, receiving SCIg treatment and who performed electrophysiolo…

CIDP; SCIg; cMAP; SNAP; ISS; INCAT; MRC; subcutaneous immunoglobulinMRCcMAPISSGeneral NeuroscienceSettore MED/26 - NeurologiaCIDPSNAPsubcutaneous immunoglobulinINCATSCIg
researchProduct

Clinical Onset and Multiple Sclerosis Relapse after SARS-CoV-2 Infection

2021

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection has been associated with several neurological disorders including headache, facial palsy, encephalitis, stroke, demyelinating disorders. The present report will discuss cases of multiple sclerosis (MS) onset and relapse both beginning early after SARS-CoV-2 infection. In both cases, magnetic resonance imaging (MRI) showed widespread bilateral subcortical and periventricular active lesions. Serum IgG against SARS-CoV-2 Spike antigens confirmed seroconversion with titers that are considered not definitely protective against possible reinfection. We hypothesize that SARS-CoV-2 infection, as previously reported for other vir…

relapseSettore MED/07 - Microbiologia E Microbiologia ClinicaonsetvirusesfungiRCOVID-19Case ReportNeurosciences. Biological psychiatry. Neuropsychiatrymultiple sclerosisRC31-1245vaccine.multiple sclerosivaccineMedicineSettore MED/26 - NeurologiaNeurology (clinical)Internal medicineRC321-571Neurology International
researchProduct

Preoperative imaging findings in patients undergoing transcranial magnetic resonance imaging-guided focused ultrasound thalamotomy

2021

AbstractThe prevalence and impact of imaging findings detected during screening procedures in patients undergoing transcranial MR-guided Focused Ultrasound (tcMRgFUS) thalamotomy for functional neurological disorders has not been assessed yet. This study included 90 patients who fully completed clinical and neuroradiological screenings for tcMRgFUS in a single-center. The presence and location of preoperative imaging findings that could impact the treatment were recorded and classified in three different groups according to their relevance for the eligibility and treatment planning. Furthermore, tcMRgFUS treatments were reviewed to evaluate the number of transducer elements turned off after…

Maletranscranial magnetic resonance; thalamotomy; neurological disordersParkinson's diseasemedicine.medical_treatmentneurological disordersNeuropathic paintranscranial magnetic resonance030218 nuclear medicine & medical imaging0302 clinical medicineThalamusMass ScreeningRadiation treatment planningScreening proceduresAged 80 and overeducation.field_of_studyMultidisciplinarymedicine.diagnostic_testSettore MED/27 - NeurochirurgiaQRSettore MED/37 - NeuroradiologiaDisease ManagementMiddle AgedMagnetic Resonance ImagingSurgery Computer-AssistedMedicineStereotaxic TechniqueSettore MED/26 - NeurologiaFemaleRadiologyAdultmedicine.medical_specialtyEssential TremorScienceClinical Decision-MakingPopulationNeuroimagingArticleFocused ultrasoundMultiple sclerosisYoung Adult03 medical and health sciencesComputed TomographyMedical researchParkinson’s Disease.Preoperative CaremedicineHumansInterventional Magnetic Resonance ImagingIn patientMovement disorderseducationHigh-intensity Focused Ultrasound AblationUltrasonography InterventionalAgedThalamotomybusiness.industryMagnetic resonance imagingthalamotomySettore FIS/07 - Fisica Applicata(Beni Culturali Ambientali Biol.e Medicin)Diseases of the nervous systemSettore MED/36 - Diagnostica Per Immagini E RadioterapiaTomography X-Ray ComputedbusinessMR-guided Focused Ultrasound030217 neurology & neurosurgeryNeurosciencePreoperative imaging
researchProduct

Impact of COVID-19 in AChR Myasthenia Gravis and the Safety of Vaccines: Data from an Italian Cohort.

2022

Background and aims. Patients with Myasthenia gravis (MG) are considered vulnerable as they may present with respiratory muscle weakness and because they are on immunosuppressive treatment; thereby, COVID-19 may have a detrimental effect on these patients. Vaccines against COVID-19 are currently available and it has been shown as they can prevent severe COVID-19 in vulnerable patients. Notwithstanding their efficacy, vaccine hesitancy has not been completely dispelled in the general population. Unfortunately, there is limited data about the safety of these vaccines in MG patients. The aims of this study are to evaluate the impact of COVID-19 in a MG cohort, the adherence to COVID-19 vaccina…

myasthenic crisisvaccineCOVID-19; SARS-CoV2; vaccine; Myasthenia gravis; neuromuscular; myasthenic crisisSARS-CoV2COVID-19neuromuscularNeurology (clinical)Myasthenia gravisNeurology international
researchProduct

Adherence and Reactogenicity to Vaccines against SARS-COV-2 in 285 Patients with Neuropathy: A Multicentric Study

2022

Background: The safety of the new vaccines against SARS-CoV-2 have already been shown, although data on patients with polyneuropathy are still lacking. The aim of this study is to evaluate the adherence to SARS-CoV-2 vaccination, as well as the reactogenicity to those vaccines in patients affected by neuropathy. Methods: A multicentric and web-based cross-sectional survey was conducted among patients affected by neuropathy from part of South Italy. Results: Out of 285 responders, n = 268 were included in the final analysis and n = 258 of them (96.3%) were fully vaccinated. Adherence to vaccination was higher in patients with hereditary neuropathies compared to others, while it was lower in …

General NeuroscienceSARS-CoV-2 infectionCIDP COVID-19 vaccines SARS-CoV-2 infection autoimmune neuropathy hereditary neuropathy neuropathy reactogenicity vaccine hesitancy vaccine safetyreactogenicityvaccine hesitancySARS-CoV-2 infection; COVID-19 vaccines; reactogenicity; vaccine safety; vaccine hesitancy; neuropathy; autoimmune neuropathy; hereditary neuropathy; CIDPneuropathyvaccine safetyCIDPhereditary neuropathyCOVID-19 vaccineautoimmune neuropathy
researchProduct

Vitamin D and Parkinson's Disease.

2022

Vitamin D is a fat-soluble secosteroid, traditionally considered a key regulator of bone metabolism, calcium and phosphorous homeostasis. Its action is made possible through the binding to the vitamin D receptor (VDR), after which it directly and indirectly modulates the expression of thousands of genes. Vitamin D is important for brain development, mature brain activity and associated with many neurological diseases, including Parkinson’s disease (PD). High frequency of vitamin D deficiency in patients with Parkinson’s disease compared to control population was noted nearly twenty years ago. This finding is of interest given vitamin D’s neuroprotective effect, exerted by the action of neur…

125-dihydroxyvitamin DDisease progressionNutrition and DieteticsParkinson DiseaseVitaminsVitamin D DeficiencyNeuroprotectionCalcium DietaryParkinson’s diseaseHumansSettore MED/26 - NeurologiaNeurodegenerationVitamin DHumanFood ScienceNutrients
researchProduct

Frequency and Correlates of Mild Cognitive Impairment in Myasthenia Gravis

2023

Background: Antibodies against acetylcholine receptors (AChRs) can also target nicotinic AChRs that are present throughout the central nervous system, thus leading to cognitive dysfunctions in patients with myasthenia gravis (MG). However, the presence of cognitive impairment in MG is controversial, and the factors that may influence this risk are almost completely unknown. In this study, the frequency of mild cognitive impairment (MCI) in MG, as well as the clinical, immunological, and behavioral correlates of MCI in MG were evaluated. Methods: A total of 52 patients with MG underwent a comprehensive assessment including motor and functional scales, serological testing, and neuropsychologi…

myasthenia gravisdepressive symptomsGeneral NeuroscienceprevalenceSettore MED/26 - Neurologiasleep disordersneuropsychological testingcognitive impairmentBrain Sciences
researchProduct

Sleep and Chronobiology as a Key to Understand Cluster Headache

2023

The cluster headache is a primary headache characterized by attacks of unilateral pain associated with ipsilateral cranial autonomic features. These attacks recur in clusters during the years alternating with periods of complete remission, and their onset is often during the night. This annual and nocturnal periodicity hides a strong and mysterious link among CH, sleep, chronobiology and circadian rhythm. Behind this relationship, there may be the influence of genetic components or of anatomical structures such as the hypothalamus, which are both involved in regulating the biological clock and contributing even to the periodicity of cluster headaches. The bidirectional relationship manifest…

circadian rhythmchronoriskcluster headacheSettore MED/26 - NeurologiaNeurology (clinical)sleepchronobiology
researchProduct